Murphy Capital Management Inc Bristol Myers Squibb CO Transaction History

Murphy Capital Management Inc

$720 Million
Q2 2022

A detailed history of Murphy Capital Management Inc transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Murphy Capital Management Inc holds 38,715 shares of BMY stock, worth $2.09 Million. This represents 0.41% of its overall portfolio holdings.

Number of Shares

38,715

Previous 39,603 2.24%

Holding current value

$2.09 Million

Previous $2.89 Million 3.08%

% of portfolio

0.41%

Previous 0.33%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 13, 2022	SELL	$72.62 - $79.98 $64,486 - $71,022	-888 Reduced 2.24%	38,715 $2.98 Million
Q1 2022 Apr 06, 2022	SELL	$61.48 - $73.72 $127,693 - $153,116	-2,077 Reduced 4.98%	39,603 $2.89 Million
Q4 2021 Jan 10, 2022	SELL	$53.63 - $62.52 $292,927 - $341,484	-5,462 Reduced 11.59%	41,680 $2.6 Million
Q3 2021 Oct 22, 2021	SELL	$59.17 - $69.31 $161,179 - $188,800	-2,724 Reduced 5.46%	47,142 $2.79 Million
Q2 2021 Jul 26, 2021	BUY	$61.91 - $67.42 $92,555 - $100,792	1,495 Added 3.09%	49,866 $3.33 Million
Q1 2021 Apr 21, 2021	BUY	$59.34 - $66.74 $179,562 - $201,955	3,026 Added 6.67%	48,371 $3.05 Million
Q4 2020 Feb 05, 2021	SELL	$57.74 - $65.43 $104,798 - $118,755	-1,815 Reduced 3.85%	45,345 $2.81 Million
Q3 2020 Oct 20, 2020	BUY	$57.43 - $63.64 $130,538 - $144,653	2,273 Added 5.06%	47,160 $2.84 Million
Q2 2020 Aug 03, 2020	BUY	$54.82 - $64.09 $66,222 - $77,420	1,208 Added 2.77%	44,887 $2.64 Million
Q1 2020 Apr 28, 2020	SELL	$46.4 - $67.43 $254,504 - $369,853	-5,485 Reduced 11.16%	43,679 $2.43 Million
Q4 2019 Feb 10, 2020	BUY	$49.21 - $64.19 $791,788 - $1.03 Million	16,090 Added 48.65%	49,164 $3.16 Million
Q3 2019 Oct 11, 2019	SELL	$42.77 - $50.71 $49,741 - $58,975	-1,163 Reduced 3.4%	33,074 $1.68 Million
Q2 2019 Jul 22, 2019	SELL	$44.62 - $49.34 $887,134 - $980,977	-19,882 Reduced 36.74%	34,237 $1.55 Million
Q1 2019 Apr 11, 2019	SELL	$45.12 - $53.8 $444,702 - $530,252	-9,856 Reduced 15.41%	54,119 $2.58 Million
Q4 2018 Feb 04, 2019	SELL	$48.76 - $63.23 $161,639 - $209,607	-3,315 Reduced 4.93%	63,975 $3.33 Million
Q3 2018 Oct 10, 2018	SELL	$55.19 - $62.25 $298,301 - $336,461	-5,405 Reduced 7.44%	67,290 $4.18 Million
Q2 2018 Jul 26, 2018	SELL	$50.53 - $62.98 $56,694 - $70,663	-1,122 Reduced 1.52%	72,695 $4.02 Million
Q1 2018 Apr 17, 2018	SELL	$59.92 - $68.98 $359,639 - $414,017	-6,002 Reduced 7.52%	73,817 $4.67 Million
Q4 2017 Jan 29, 2018	SELL	$59.94 - $65.35 $16,363 - $17,840	-273 Reduced 0.34%	79,819 $4.89 Million
Q3 2017 Oct 19, 2017	BUY	$55.23 - $63.74 $4.42 Million - $5.11 Million	80,092	80,092 $5.11 Million

Others Institutions Holding BMY

# of Institutions

2,407

Shares Held

1.5B

Call Options Held

29.7M

Put Options Held

32.2M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $115B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Murphy Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Murphy Capital Management Inc with notifications on news.

Account

Murphy Capital Management Inc Bristol Myers Squibb CO Transaction History